Maxitrol (Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone)

The formulation combines three mechanisms: dexamethasone activates glucocorticoid receptors to suppress inflammatory mediators; neomycin binds the bacterial 30 S ribosomal subunit, halting protein synthesis; and polymyxin B disrupts bacterial cell membranes, leading to cell death. Together they provide simultaneous anti‑inflammatory and antibacterial effects.

The dosing regimen for Maxitrol is determined by the prescribing eye‑care professional based on the specific condition, severity and patient response. The prescriber will provide detailed instructions on the number of drops, frequency and duration of therapy.

Safety data for Maxitrol in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified health‑care provider.

To order Maxitrol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent eye drops, Maxitrol offers a combined corticosteroid and broad‑spectrum antibacterial effect, reducing the need for multiple products. Alternatives may include separate steroid and antibiotic drops, but Maxitrol simplifies therapy and can improve adherence when both actions are clinically indicated.

Store Maxitrol at room temperature, preferably below 25 °C, in the original container. Protect the suspension from light, moisture and extreme temperatures. Keep the bottle tightly closed when not in use and discard any product that appears discolored or contains particles.

Maxitrol is applied as an ocular drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and instill the prescribed number of drops without touching the tip of the bottle to the eye or surrounding structures.

Serious risks include allergic reactions, secondary ocular infections, corneal ulceration, increased intra‑ocular pressure leading to glaucoma, cataract formation with prolonged use, and systemic corticosteroid effects if absorbed in significant amounts.

Maxitrol should be avoided in patients with known hypersensitivity to any of its components, in eyes with viral or fungal infections, and in individuals where corticosteroid use is contraindicated, such as uncontrolled glaucoma or certain systemic infections, unless directed by a specialist.